Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 51

1.

Targeted imaging and therapy of brain cancer using theranostic nanoparticles.

Bhojani MS, Van Dort M, Rehemtulla A, Ross BD.

Mol Pharm. 2010 Dec 6;7(6):1921-9. doi: 10.1021/mp100298r. Epub 2010 Oct 27. Review.

2.

A new intravenous fat emulsion containing soybean oil, medium-chain triglycerides, olive oil, and fish oil: a single-center, double-blind randomized study on efficacy and safety in pediatric patients receiving home parenteral nutrition.

Goulet O, Antébi H, Wolf C, Talbotec C, Alcindor LG, Corriol O, Lamor M, Colomb-Jung V.

JPEN J Parenter Enteral Nutr. 2010 Sep-Oct;34(5):485-95. doi: 10.1177/0148607110363614.

PMID:
20852176
3.

Metallic nanoparticles: technology overview & drug delivery applications in oncology.

Ahmad MZ, Akhter S, Jain GK, Rahman M, Pathan SA, Ahmad FJ, Khar RK.

Expert Opin Drug Deliv. 2010 Aug;7(8):927-42. doi: 10.1517/17425247.2010.498473. Review.

PMID:
20645671
4.

Nanoparticle technologies for cancer therapy.

Alexis F, Pridgen EM, Langer R, Farokhzad OC.

Handb Exp Pharmacol. 2010;(197):55-86. doi: 10.1007/978-3-642-00477-3_2. Review.

PMID:
20217526
5.

RGD peptide functionalized and reconstituted high-density lipoprotein nanoparticles as a versatile and multimodal tumor targeting molecular imaging probe.

Chen W, Jarzyna PA, van Tilborg GA, Nguyen VA, Cormode DP, Klink A, Griffioen AW, Randolph GJ, Fisher EA, Mulder WJ, Fayad ZA.

FASEB J. 2010 Jun;24(6):1689-99. doi: 10.1096/fj.09-139865. Epub 2010 Jan 14.

6.

Multifunctional imaging nanoprobes.

Jarzyna PA, Gianella A, Skajaa T, Knudsen G, Deddens LH, Cormode DP, Fayad ZA, Mulder WJ.

Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2010 Mar-Apr;2(2):138-50. doi: 10.1002/wnan.72. Review.

7.

Role of nanocarrier systems in cancer nanotherapy.

Mozafari MR, Pardakhty A, Azarmi S, Jazayeri JA, Nokhodchi A, Omri A.

J Liposome Res. 2009;19(4):310-21. doi: 10.3109/08982100902913204. Review.

PMID:
19863166
8.

Iron oxide core oil-in-water emulsions as a multifunctional nanoparticle platform for tumor targeting and imaging.

Jarzyna PA, Skajaa T, Gianella A, Cormode DP, Samber DD, Dickson SD, Chen W, Griffioen AW, Fayad ZA, Mulder WJ.

Biomaterials. 2009 Dec;30(36):6947-54. doi: 10.1016/j.biomaterials.2009.09.004. Epub 2009 Sep 23.

9.

Nanomedicine: perspective and promises with ligand-directed molecular imaging.

Pan D, Lanza GM, Wickline SA, Caruthers SD.

Eur J Radiol. 2009 May;70(2):274-85. doi: 10.1016/j.ejrad.2009.01.042. Epub 2009 Mar 5. Review.

PMID:
19268515
10.

Cellular compartmentalization of internalized paramagnetic liposomes strongly influences both T1 and T2 relaxivity.

Kok MB, Hak S, Mulder WJ, van der Schaft DW, Strijkers GJ, Nicolay K.

Magn Reson Med. 2009 May;61(5):1022-32. doi: 10.1002/mrm.21910.

11.

Phase I clinical trial of liposomal-encapsulated doxorubicin citrate and docetaxel, associated with trastuzumab, as neo-adjuvant treatment in stages II and IIIA, HER2-overexpressing breast cancer patients. GEICAM 2003-03 study.

Antón A, Ruiz A, Seguí MA, Calvo L, Muñoz M, Lao J, Sancho F, Fernández L.

Ann Oncol. 2009 Mar;20(3):454-9. doi: 10.1093/annonc/mdn663. Epub 2008 Dec 11.

PMID:
19074216
12.

Molecular imaging of tumor angiogenesis using alphavbeta3-integrin targeted multimodal quantum dots.

Mulder WJ, Castermans K, van Beijnum JR, Oude Egbrink MG, Chin PT, Fayad ZA, Löwik CW, Kaijzel EL, Que I, Storm G, Strijkers GJ, Griffioen AW, Nicolay K.

Angiogenesis. 2009;12(1):17-24. doi: 10.1007/s10456-008-9124-2. Epub 2008 Dec 9.

PMID:
19067197
13.

Nanotechnology in medical imaging: probe design and applications.

Cormode DP, Skajaa T, Fayad ZA, Mulder WJ.

Arterioscler Thromb Vasc Biol. 2009 Jul;29(7):992-1000. doi: 10.1161/ATVBAHA.108.165506. Epub 2008 Dec 4. Review.

14.

Improved magnetic resonance molecular imaging of tumor angiogenesis by avidin-induced clearance of nonbound bimodal liposomes.

van Tilborg GA, Mulder WJ, van der Schaft DW, Reutelingsperger CP, Griffioen AW, Strijkers GJ, Nicolay K.

Neoplasia. 2008 Dec;10(12):1459-69.

15.

Factors affecting the clearance and biodistribution of polymeric nanoparticles.

Alexis F, Pridgen E, Molnar LK, Farokhzad OC.

Mol Pharm. 2008 Jul-Aug;5(4):505-15. doi: 10.1021/mp800051m. Epub 2008 Aug 4. Review.

16.

Liposomal glucocorticoids as tumor-targeted anti-angiogenic nanomedicine in B16 melanoma-bearing mice.

Banciu M, Metselaar JM, Schiffelers RM, Storm G.

J Steroid Biochem Mol Biol. 2008 Jul;111(1-2):101-10. doi: 10.1016/j.jsbmb.2008.05.004. Epub 2008 Jul 7.

PMID:
18602825
17.

Antitumor activity and tumor localization of liposomal glucocorticoids in B16 melanoma-bearing mice.

Banciu M, Fens MH, Storm G, Schiffelers RM.

J Control Release. 2008 Apr 21;127(2):131-6. doi: 10.1016/j.jconrel.2008.01.008. Epub 2008 Jan 30.

PMID:
18291548
18.

Detecting and treating cancer with nanotechnology.

Hartman KB, Wilson LJ, Rosenblum MG.

Mol Diagn Ther. 2008;12(1):1-14. Review.

PMID:
18288878
19.

MRI contrast agents: current status and future perspectives.

Strijkers GJ, Mulder WJ, van Tilborg GA, Nicolay K.

Anticancer Agents Med Chem. 2007 May;7(3):291-305. Review.

PMID:
17504156
20.

In vivo imaging of siRNA delivery and silencing in tumors.

Medarova Z, Pham W, Farrar C, Petkova V, Moore A.

Nat Med. 2007 Mar;13(3):372-7. Epub 2007 Feb 25.

PMID:
17322898

Supplemental Content

Support Center